Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats
- 1 January 2010
- journal article
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 133 (1) , 25-32
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- N-Glycosylation Pattern of E2 Glycoprotein from Classical Swine Fever VirusJournal of Proteome Research, 2008
- Highly protective E2–CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goatsJournal of Biotechnology, 2008
- Origin and evolution of viruses causing classical swine fever in CubaVirus Research, 2005
- A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challengeVaccine, 2005
- Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFVVaccine, 2005
- The E2 Glycoprotein of Classical Swine Fever Virus Is a Virulence Determinant in SwineJournal of Virology, 2005
- Classical Swine Fever Virus Strain ‘C’. How Long is it Detectable After Oral Vaccination?Journal of Veterinary Medicine, Series B, 2004
- Heterologous Gene Expression from Transmissible Gastroenteritis Virus Replicon ParticlesJournal of Virology, 2002
- Efficacy of an Inactivated Feline Leukemia Virus VaccineAIDS Research and Human Retroviruses, 1996
- Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosisVeterinary Microbiology, 1986